The FDA has recently approved Zepbound (tirzepatide) as a treatment for moderate to severe OSA in adults with obesity marking a new chapter in sleep apnea care that brings hope, especially for patients looking for a less equipment-heavy approach
Call or text us today to schedule your consultation.
Backed by Science Cited in 1,500+ scientific publications, Akkermansia muciniphila is recognized as a promising probiotic in reviews from Microbial Biotechnology (PMC6801136), Journal of Applied Microbiology (OUP, 130:6, 1813-1830), Gut Microbes (PMC11364076), and Frontiers in Microbiology (Front Microbiol, 2024) for its role in metabolic health, gut barrier integrity, and immune function
Timing tip: Take fiber between meals rather than with meals
This absorption route has precedent
No, for the vast majority of patients, fatigue is a temporary side effect that occurs during the initial weeks of treatment or after a dose increase